Clinical Trials Directory

Trials / Completed

CompletedNCT02325271

Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With Biomarkers

Intra-individual Variability and Circadian Rhythm of Systemic Vascular Endothelial Growth Factor (VEGF) Levels and Interaction With Biomarkers of Inflammation in Subjects With Normal Glucose Tolerance (NGT) and Patients With Type 2 Diabetes Without Diabetic Macular Edema (DME)

Status
Completed
Phase
Study type
Observational
Enrollment
40 (actual)
Sponsor
GWT-TUD GmbH · Academic / Other
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Accepted

Summary

The study evaluates the intra-individual variability of VEGF levels over a period of 6 months as well as the circadian variation of VEGF levels, both under standardized conditions in patients with type 2 diabetes without DME and matched subjects with normal glucose tolerance (NGT). Secondary objectives of the study are to evaluate the relationship of individual VEGF-levels to biomarkers of inflammation, HbA1c and major cardiovascular risk factors.

Conditions

Interventions

TypeNameDescription
OTHERFrequent blood and urine sampling and blood pressure measurementBlood and urine sampling for the determination of VEGF and biomarkers

Timeline

Start date
2015-02-01
Primary completion
2015-10-01
Completion
2016-01-01
First posted
2014-12-24
Last updated
2017-09-06

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02325271. Inclusion in this directory is not an endorsement.

Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With Biomarkers (NCT02325271) · Clinical Trials Directory